Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
June 21, 2022
AI Magazine
“Face2Gene is a healthcare app developed by FDNA, an American AI company. Specifically designed for healthcare professionals, the app allows doctors to easily diagnose patients for genetic disorders and their variants. FDNA’s app uses deep learning algorithms to help identify syndromes and its proprietary technology converts a patient photo into de-identified mathematical facial descriptors that are compared to syndrome-specific computational-based classifiers to quantify similarity. This results in a prioritized list of syndromes with similar morphology. The AI in the technology also suggests likely phenotypic traits and genes to assist in feature annotation and syndrome prioritization.”
Based on the article from AI Magazine, FDNA is recognized as one of the top 10 companies offering facial recognition software. Face2Gene, utilizes advanced AI algorithms to analyze facial features and expedite the diagnosis of genetic disorders. This facial recognition software compares patient photos to a comprehensive database of known genetic conditions, providing quick and accurate diagnostic insights. FDNA’s innovative approach has revolutionized the healthcare industry, making genetic disorder detection more efficient and accessible.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…